Gestational Trophoblastic Disease Treatment Cost in Delhi
Looking for affordable treatment for Gestational Trophoblastic Disease (GTD) in Delhi? Delhi is a preferred destination for advanced gynecologic oncology care, offering comprehensive GTD treatment at super specialty hospitals. Patients from India and abroad choose Delhi for its experienced gynecologic oncologists, modern cancer care facilities, and supportive patient services.
Minimum Price:
₹14,000/-
Maximum Price:
₹28,000/-
*Treatment cost may vary based on patient condition, procedures, and hospital stay.
Fill the form for an exact quotation.
15,000+
Patient Treated
10,000+
Successful Surgeries
5,000+
Happy Patients
20+
Years of Experience
Awards & Recognitions
Globally Accredited Hospitals (NABH, JCI, & ISO Certified)
Smiles That Tell Real Stories
The doctors were professional ... Read More
I was scared and exhausted bef... Read More
MedsurgeIndia guided us from t... Read More
Before treatment, I was anxiou... Read More
I was overwhelmed by my diagno... Read More
MedsurgeIndia assisted us in c... Read More
I had constant worry and disco... Read More
MedsurgeIndia guided me throug... Read More
I felt weak, anxious, and scar... Read More
MedsurgeIndia coordinated ever... Read More
I was nervous and exhausted be... Read More
Traveling from abroad, I was a... Read More
I experienced constant fatigue... Read More
MedsurgeIndia helped me select... Read More
Before treatment, I was anxiou... Read More
I was extremely worried and fa... Read More
MedsurgeIndia helped us find t... Read More
My diagnosis left me anxious a... Read More
I felt uncertain and scared ab... Read More
Being treated in India was rea... Read More
Gestational Trophoblastic Disease Treatment Cost in Delhi
The cost of treating Gestational Trophoblastic Disease in Delhi generally ranges between 14,000 to 28,000, depending on the type of disease, treatment protocol, and the patient’s overall health. Costs vary depending on whether the condition is managed with chemotherapy alone, requires surgical intervention, or involves high-risk disease protocols and extended follow-up care.
Hospitals in Delhi provide high-quality oncologic care at competitive costs, supported by multidisciplinary teams and advanced diagnostic tools.
Factors Affecting GTD Treatment Cost
The overall cost may vary depending on:
- Type and stage of GTD (hydatidiform mole, invasive mole, choriocarcinoma, PSTT, ETT)
- Treatment modality (single-agent vs combination chemotherapy, surgery)
- Hospital infrastructure and gynecologic oncology expertise
- Diagnostic tests and imaging procedures
- Hospital stay, medications, and follow-up care
Additional Factors for International Patients
International patients should also consider:
- Medical visa and travel arrangements
- Accommodation and meals during treatment
- Interpreter or language assistance, if required
- Duration of stay for treatment cycles and follow-up visits
About Gestational Trophoblastic Disease
Gestational Trophoblastic Disease (GTD) refers to a group of rare tumors that originate from abnormal growth of placental tissue after conception. GTD includes benign conditions such as complete and partial hydatidiform mole and malignant forms such as invasive mole, choriocarcinoma, placental site trophoblastic tumor (PSTT), and epithelioid trophoblastic tumor (ETT). Early diagnosis and appropriate treatment are crucial for effective management and long-term survival.
Treatment Options for GTD
Treatment for Gestational Trophoblastic Disease is individualized based on disease type, risk score, and patient factors:
- Suction Curettage
Used primarily for the removal of molar tissue in non-malignant GTD cases, often followed by close monitoring of beta-hCG levels. - Chemotherapy
Single-agent chemotherapy (e.g., methotrexate or actinomycin-D) is typically used for low-risk GTD, while combination chemotherapy (e.g., EMA-CO) is used for high-risk or malignant cases. - Surgical Intervention
Surgery, such as a hysterectomy, may be recommended in selected cases, especially in women who do not desire fertility or when the disease persists despite chemotherapy. - High-Risk Protocols and Follow-Up
Patients with high-risk GTD require intensive chemotherapy regimens and prolonged monitoring of beta-hCG levels until remission is confirmed.
Diagnostic Tests for GTD
Before and during treatment, patients typically undergo tests such as quantitative beta-hCG measurement, pelvic ultrasound, chest imaging (X-ray or CT), and additional scans to assess disease spread. These tests guide diagnosis, risk categorization, and treatment planning.
Recovery and Monitoring
Recovery and monitoring depend on the type of GTD and treatment received. Regular follow-up with beta-hCG testing is essential to ensure remission and detect any recurrence early. Patients may require long-term surveillance, especially in high-risk cases.
Why Choose Delhi for GTD Treatment?
Delhi is preferred for GTD treatment because of:
- Affordable access to advanced gynecologic oncology care
- Experienced gynecologic oncologists and multidisciplinary cancer teams
- Super specialty hospitals with modern diagnostic and treatment facilities
- NABH/ISO-accredited cancer centers with comprehensive support services
- Dedicated services for international patients
Why Choose Medsurge India?
Medsurge India ensures a smooth treatment journey by:
- Connecting patients with leading gynecologic oncologists and hospitals
- Providing transparent cost estimates
- Assisting with medical visa, travel, and accommodation
- Offering dedicated patient coordinators
- Supporting post-treatment follow-up and rehabilitation
Frequently Asked Questions
Q. What is the cost of Gestational Trophoblastic Disease treatment in Delhi?
A. The cost depends on the type of GTD, treatment modality, hospital, and duration of follow-up.
Q. What treatment options are available for GTD?
A. Treatment includes suction curettage, chemotherapy (single-agent or combination), surgical intervention when needed, and follow-up monitoring.
Q. How long does GTD treatment take?
A. The duration varies by disease type and response to therapy; it may range from weeks for low-risk disease to months for high-risk cases requiring combination chemotherapy.
Q. What is the success rate of Gestational Trophoblastic Disease treatment in Delhi?
A. With early diagnosis and appropriate management, GTD (especially low-risk disease) has a high success rate, with overall remission rates often above 90% in experienced centers.
 (1).png)